Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Ahlberg Gregory A, Chief Executive Officer. Insider active across 1 company, notably Abbott Laboratories. In total, 7 filings have been recorded. History available since 1 October 2021. The latest transaction was disclosed on 28 February 2023 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Ahlberg Gregory A is Directeur Général and Senior Vice President at Abbott Laboratories. He has 7 filings in total, and across the 7 sampled filings, the modal transaction nature is Tax withholding, with a date range from 2021-10-05 to 2023-03-02.